KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Return on Equity: 2010-2025

Historic Return on Equity for Ionis Pharmaceuticals (IONS) over the last 15 years, with Sep 2025 value amounting to -0.41%.

  • Ionis Pharmaceuticals' Return on Equity rose 37.00% to -0.41% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.41%, marking a year-over-year increase of 37.00%. This contributed to the annual value of -0.93% for FY2024, which is 17.00% down from last year.
  • According to the latest figures from Q3 2025, Ionis Pharmaceuticals' Return on Equity is -0.41%, which was up 15.30% from -0.49% recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Return on Equity registered a high of 0.01% during Q3 2022, and its lowest value of -1.31% during Q2 2024.
  • Its 3-year average for Return on Equity is -0.83%, with a median of -0.78% in 2024.
  • Its Return on Equity has fluctuated over the past 5 years, first slumped by 114bps in 2021, then surged by 111bps in 2022.
  • Ionis Pharmaceuticals' Return on Equity (Quarterly) stood at -0.05% in 2021, then slumped by 42bps to -0.46% in 2022, then slumped by 58bps to -1.05% in 2023, then soared by 32bps to -0.73% in 2024, then skyrocketed by 37bps to -0.41% in 2025.
  • Its Return on Equity stands at -0.41% for Q3 2025, versus -0.49% for Q2 2025 and -0.86% for Q1 2025.